
Examine recent clinical evidence that high-dose antioxidant treatments can worsen outcomes in critical illness and broader supplementation contexts.
Key Takeaways
- High-dose intravenous vitamin C burn trial was stopped early for increased deaths
- Prior sepsis trial showed higher death or organ failure with the same vitamin C dose
- Excess vitamin C can form oxalate and act prooxidant in iron-rich injured tissues
